- Q1 2024 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2024$1.09 (-9.17%)Earnings
- Q4 2023 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 21, 2024$1.31 (+28.43%)Earnings
- Q3 2023 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2023$0.79 (+6.68%)Earnings
- X4 Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- X4 Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 X4 Pharmaceuticals Inc Earnings Call TranscriptAug 10, 2023$1.05 (-35.98%)Earnings
- X4 Pharmaceuticals Inc 4WHIM Phase 3 Clinical Trial Update Call TranscriptMay 16, 2023
- Q1 2023 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023$1.54 (+4.05%)Earnings
- Q4 2022 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 21, 2023$0.8954 (+0.97%)Earnings
- X4 Pharmaceuticals Inc To Discuss Key Top-Line 4WHIM Trial Results TranscriptNov 29, 2022
- X4 Pharmaceuticals Inc at Stifel Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2022$1.89 (-3.57%)Earnings
- X4 Pharmaceuticals Inc at Canaccord Genuity Growth Conference TranscriptAug 11, 2022
- Q2 2022 X4 Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022$1.27 (-1.55%)Earnings
- Q1 2022 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 12, 2022$1.04 (-0.95%)Earnings
- X4 Pharmaceuticals Inc at Canaccord Genuity Horizons in Oncology Conference (Virtual) TranscriptApr 14, 2022
- X4 Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 11, 2022
- Q4 2021 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 17, 2022$1.77 (-10.61%)Earnings
- X4 Pharmaceuticals Inc at B Riley Oncology Conference (Virtual) TranscriptJan 28, 2022
- Q3 2021 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 04, 2021$5.15 (-8.04%)Earnings
- X4 Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Q2 2021 X4 Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2021$5.66 (-4.55%)Earnings
- Q1 2021 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2021$8.12 (+1.50%)Earnings
- Q4 2020 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 04, 2021$9.18 (-5.75%)Earnings
- X4 Pharmaceuticals Inc Dr. Ragan Discusses X4's Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases TranscriptDec 23, 2020
- Q3 2020 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020$6.01 (-6.68%)Earnings
- Q2 2020 X4 Pharmaceuticals Inc Earnings Call TranscriptJul 30, 2020$7.73 (-3.50%)Earnings
- X4 Pharmaceuticals Inc Post-EHA Corporate Update TranscriptJun 12, 2020
- Q1 2020 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2020$8.56 (-4.89%)Earnings
- X4 Pharmaceuticals Inc Virtual Analyst Day - A Deep Dive into WHIM Syndrome TranscriptApr 07, 2020
- Q4 2019 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 12, 2020$8.13 (-5.24%)Earnings
- Q3 2019 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2019$13.41 (+3.79%)Earnings
X4 Pharmaceuticals Inc at B Riley Oncology Conference (Virtual) Transcript
Good afternoon. This is Mayank Mamtani. Thanks all for joining us for day two of B. Riley Virtual Oncology Investor Conference. Our next fireside chat is with X4 Pharmaceuticals. I'm pleased to have with me, Paula Ragan, our CEO and President.
Paula, we appreciate you being part of the conference. Maybe to kick us off, it would be -- would love to hear sort of a little bit of state of the union on how to think about X4 in 2022 after a very eventful couple of years and obviously a very pivotal year, this year, with your Phase 3 readout and also expansion of your lead program into different indications.
Thank you so much, Mayank. Appreciate it, and I appreciate the B. Riley team for having us today.
So as you kind of opened up, X4 has an amazing transformative year ahead for us as we think about building the two key pillars of our business.
The first pillar is around primary immunodeficiencies, where we have an ongoing Phase 3
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)